|
|
|
| Effect of drugs combined with cognitive behavior therapy for recurrent depressive disorder |
| SU Jin-ge1 JIANG Hai-jun2 LIU Xiao-mei |
1. Department of Psychiatry, Huizhou Second People′s Hospital, Guangdong Province, Huizhou 516100, China;
2. Department of Psychiatry, Huizhou Demobilized Veterans Hospital, Guangdong Province, Huizhou 516100, China |
|
|
|
|
Abstract Objective To observe the effect of drugs combined with cognitive behavior therapy for recurrent depressive disorder. Methods From June 2019 to September 2020, 100 patients with recurrent depressive disorder in Huizhou Second People′s Hospital and Huizhou Demobilized Veterans Hospital were selected, and they were divided into two groups according to the admission time, 50 cases in each group. The control group was given drug treatment, and the study group was given drug combined with cognitive behavior therapy. The Hamilton depression scale (HAMD), selfrating depression scale (SDS) and the MOS item short from health survey (SF-36) scores before and after treatment and incidence of adverse reactions were compared and analyzed between the two groups. Results There was no significant difference in HAMD score between the two groups before treatment (P>0.05). At 4 and 8 weeks of treatment, the HAMD scores of the two groups were lower than those before treatment, and those in the study group were lower than those in the control group, the differences were statistically significant (P<0.05). There was no significant difference in SDS score between the two groups before treatment (P>0.05). At 4 and 8 weeks of treatment, the SDS scores of the two groups were lower than those before treatment, and those in the study group were lower than those in the control group,the differences were statistically significant (P<0.05). There was no significant difference in SF-36 score between the two groups before treatment (P>0.05). At 4 and 8 weeks of treatment, the SF-36 scores of the two groups were higher than those before treatment, and those in the study group were higher than those in the control group, the differences were statistically significant (P<0.05). There was no significant difference in the total incidence of adverse reactions such as headache, constipation, nausea, tachycardia, dry mouth, drowsiness, increase in appetite, and weight gain between the two groups (P>0.05). Conclusion For patients with recurrent depressive disorder, drugs combined with cognitive behavioral therapy can effectively improve clinical symptoms, with high security, and the clinical value is remarkable.
|
|
|
|
|
|
| [1] |
王先丹，耿懿.联合心理干预与西酞普兰对抑郁症患者症状、认知功能的疗效分析[J].中国现代医药杂志，2018，20（1）：65-67.
|
| [2] |
任峰，张坚学，宋翠林，等.药物合并正念认知疗法对复发性抑郁障碍残留症状的疗效[J].中国心理卫生杂志，2019，33（4）：248-252.
|
| [3] |
冯娜.正念训练对复发性抑郁障碍病人抑郁情绪及自尊的影响[J].护理研究，2016，30（21）：2682-2683.
|
| [4] |
付晓凡，姚金兰，钱敏才，等.老年抑郁症认知损害及非药物干预研究进展[J].护士进修杂志，2019，34（10）：901-904.
|
| [5] |
谢新凤，邓书禄，李诗燕，等.首发与复发抑郁症患者记忆功能改善的比较[J].健康必读，2020，（19）：33-34.
|
| [6] |
徐良雄，石聿树，熊昌娥，等.抑郁障碍患者正念认知疗法干预后生活质量病例对照研究[J].中国健康心理学杂志，2020，28（3）：374-377.
|
| [7] |
矫健萍，胡健波，黄满丽.伏硫西汀对抑郁症疗效、认知功能和BDNF 影响的研究进展[J].中国现代医生，2020，58（9）：184-188.
|
| [8] |
李仙，李建琼.抑郁症的认知功能障碍研究[J].中国社区医师，2020，36（11）：89-90.
|
| [9] |
王磊，白华，王凤杰，等.认知行为疗法在抑郁患者中的应用疗效对比研究[J].国际精神病学杂志，2019，46（1）：161-163，171.
|
| [10] |
周建，岳玉川，何昌九，等.评价心理认知护理干预实施在抑郁症患者中的护理效果[J].家庭医药，2017，（7）：236-237.
|
| [11] |
范嘉晨，邢炯，柳荣荣，等.计算机认知功能训练治疗抑郁症的研究进展[J].国际精神病学杂志，2019，46（6）：971-974.
|
| [12] |
朱德超.男性偏执型精神分裂症康复期分散内观认知疗法联合药物对临床疗效、 复发率及依从性影响分析[J].社区医学杂志，2017，15（5）：42-45.
|
| [13] |
祁继鹏，平丽慧，魏冬，等.认知行为疗法加药物治疗对首发精神分裂症的疗效观察[J].国际精神病学杂志，2018，45（4）：611-614.
|
| [14] |
任振宇.抑郁的复发预防：正念认知疗法vs 抗抑郁药维持疗法[J].临床药物治疗杂志，2016，14（2）：91.
|
| [15] |
王辉，王玲，夏明净，等.文拉法辛缓释剂与氟西汀治疗复发性抑郁障碍的临床护理效果观察[J].中国医药指南，2018，16（27）：254-255.
|
| [16] |
王恩霞，李彩芳，刘元华.团体认知行为治疗对老年抑郁症的疗效[J].中国保健营养，2017，27（8）：271.
|
| [17] |
宋学叶.药物治疗和认知行为疗法结合心理社会支持治疗抑郁症的临床效果[J].医学美学美容，2019，28（13）：70-71.
|
| [18] |
黄海涛.认知行为疗法联合帕罗西汀与帕罗西汀单用治疗抑郁症的效果对照分析[J].中国实用医药，2018，13（21）：193-194.
|
|
|
|
